Core Insights - Align Technology, Inc. (ALGN) specializes in designing and marketing Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners, with a market capitalization of approximately $13.6 billion [1] Stock Performance - Over the past 52 weeks, ALGN stock has decreased by 4.1%, while the S&P 500 Index has increased by roughly 13%, indicating underperformance relative to the broader market [2] - In 2026, ALGN stock has rebounded with a year-to-date increase of 21.7%, contrasting with a marginal gain in the S&P 500 Index, suggesting renewed investor confidence [2] Sector Comparison - The State Street Health Care Select Sector SPDR ETF (XLV) has risen by 6.5% over the last 52 weeks, outperforming ALGN during that period; however, ALGN has surpassed the ETF's 1.3% gain in 2026 [3] Earnings Report - Following the release of Q4 fiscal 2025 earnings on February 4, ALGN stock experienced a 2.7% increase on the announcement day, followed by gains of 8.9% and 6.8% in the subsequent trading sessions [6] - Revenue for Q4 fiscal 2025 grew by 5.3% year over year to $1.05 billion, exceeding analyst expectations of $1.03 billion [6] - Adjusted EPS rose by 34.8% to $3.29, surpassing the Street estimate of $2.97 [6] Growth Drivers - The growth in revenue was driven by strong performance within dental service organizations (DSOs) and significant increases in clear aligner volumes [7] - Management is focusing on global expansion and increasing orthodontic usage among children and teenagers, which supports a positive outlook for stable end-market conditions [7] Future Expectations - For fiscal year 2026, analysts project diluted EPS to increase by 7.3% year over year to $9.08, indicating steady earnings momentum [8] - Align has exceeded EPS estimates in three of the past four quarters, with only one miss [8] - The overall rating for ALGN stock is "Moderate Buy," with eight out of 15 analysts issuing a "Strong Buy" rating, six recommending "Hold," and one suggesting "Moderate Sell" [8]

Company Overview - Align Technology, Inc. (ALGN) has a market capitalization of $11.2 billion and specializes in developing and providing Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services globally [1] Financial Performance - The company is expected to announce its fiscal Q4 2025 results on February 4, with analysts predicting earnings of $2.47 per share, reflecting a 26% increase from $1.96 per share in the same quarter last year [2] - For fiscal 2025, analysts forecast an EPS of $8.18, which represents a 16.7% increase from $7.01 in fiscal 2024 [3] - Following the Q3 2025 results on October 29, ALGN shares rose by 4.9%, with adjusted EPS reported at $2.61 and revenue at $995.7 million, surpassing consensus estimates [5] Market Performance - Over the past 52 weeks, ALGN stock has declined by 22.5%, underperforming the S&P 500 Index, which rose by 16.2%, and the State Street Health Care Select Sector SPDR ETF, which returned 13.3% [4] Analyst Sentiment - The consensus rating for ALGN stock is "Moderate Buy," with 15 analysts providing coverage: eight rated it as "Strong Buy," six as "Hold," and one as "Moderate Sell" [6] - The average analyst price target for ALGN is $171.38, indicating a potential upside of 2.2% from current levels [6]

Core Insights - Align Technology, Inc. has a market capitalization of $10.2 billion and is recognized for its Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners, providing advanced orthodontic and restorative digital solutions globally [1] Stock Performance - Over the past 52 weeks, Align Technology's shares have decreased by 37.5%, underperforming the S&P 500 Index, which gained 11% during the same period [2] - Year-to-date, the stock has dropped 31.6%, while the S&P 500 has risen by 12.3% [2] Recent Financial Results - Following the Q3 2025 results released on October 29, shares surged by 4.9%, with adjusted EPS at $2.61 and revenue reaching $995.7 million, surpassing consensus estimates [4] - Align Technology raised its Q4 revenue forecast to between $1.03 billion and $1.05 billion, anticipating mid-single-digit growth in Clear Aligner volumes [4] Earnings Expectations - For the fiscal year ending December 2025, analysts project a 16.7% year-over-year increase in EPS to $8.18 [5] - The company's earnings surprise history is mixed, with two beats and two misses in the last four quarters [5] Analyst Ratings - Among 14 analysts covering Align Technology, the consensus rating is a "Moderate Buy," consisting of eight "Strong Buy" ratings, five "Holds," and one "Moderate Sell" [5] - This rating configuration is slightly less bullish than three months ago, which had nine "Strong Buy" ratings [6] Price Targets - Evercore ISI raised its price target on Align Technology to $170, maintaining an "Outperform" rating [7] - The mean price target of $173.25 indicates a potential upside of 21.5% from the current price, while the highest target of $205 suggests a 43.8% upside [7]